Vor Biopharma
VOR
VOR
60 hedge funds and large institutions have $134M invested in Vor Biopharma in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 21 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
60
Holders Change
+1
Holders Change %
+1.69%
% of All Funds
0.88%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
21
Reduced
14
Closed
5
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
-$2K
Top Buyers
| 1 |
MCM
MAI Capital Management
Independence,
Ohio
|
$804K |
| 2 |
Morgan Stanley
New York
|
$774K |
| 3 |
BlackRock
New York
|
$5.07M |
| 4 |
Northern Trust
Chicago,
Illinois
|
$894K |
| 5 |
Barclays
London,
United Kingdom
|
$117K |
